首页> 美国政府科技报告 >Branched-Chain Amino and Keto Acid Biochemistry and Cellular Biology in Central Nervous System Diseases
【24h】

Branched-Chain Amino and Keto Acid Biochemistry and Cellular Biology in Central Nervous System Diseases

机译:中枢神经系统疾病中支链氨基酸和酮酸生物化学与细胞生物学

获取原文

摘要

Branched-chain amino acids (BCAAs: leucine, isoleucine, and valine) are essential components of many biochemical and biological processes. There are well-established pathways, such as fatty acid synthesis and oxidation, anabolic use to synthesize new proteins, and anaplerotic use to generate or sustain metabolic intermediate molecules, which we define as 'classical' pathways here. Recently new 'non-classical' roles for BCAAs have been discovered, most notably for leucine. Leucine has been shown to initiate protein synthesis by increasing translational protein complex activities and to suppress feeding behaviors in rats; both phenomena are at least partially mediated through the mammalian target of rapamycin (mTOR) kinase cascade. Our lab previously identified another potential non-classical pathway independent of mTOR, acting through the hypoxia inducible factor (HIF) transcriptional regulatory protein. Our goal for the first line of research for this work was to validate and further elaborate that leucine promotes HIF transcriptional activation through its 2-oxoacid derivative, alpha-ketoisocaproic acid using an in vitro glioma cell line trangenically altered to express a reporter protein for HIF-alpha degradative cycle activity. The 2-oxoacid was found to increase the half-life of the HIF-1alpha component of the HIF-1 heterodimeric complex in normal oxygen conditions and induce secretion of a known HIF-1 transcriptional protein target independent of mTOR activation.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号